{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:21:01Z","timestamp":1789924861821,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>In recent years, novel echocardiographic parameters, known as myocardial work (MW) parameters, have been introduced into clinical practice for the assessment of contractile function. This study aimed to provide a technical characterization of the interrelations among these MW parameters and evaluate their differences between patients with non-obstructive (nHCM) and obstructive hypertrophic cardiomyopathy (oHCM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>One-hundred-eighteen patients with HCM, including 68\u2005nHCM and 50 oHCM patients were assessed. Global longitudinal strain (GLS) and derived global MW parameters\u2014including global work index (GWI), global constructive work (GCW), global wasted work (GWW), and global work efficiency (GWE)\u2014were determined by 2D-speckle tracking echocardiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In all HCM cohorts, GLS demonstrated a strong, significant correlation with GWI and GCW (\n                      <jats:italic>r<\/jats:italic>\n                      : \u22120.619 to \u22120.818), whereas the correlation between GLS and GWW was considerably weaker (\n                      <jats:italic>r<\/jats:italic>\n                      : 0.320 to 0.373), consistent in both univariate correlation and multiple regression analyses. A strong, significant correlation was observed between GWI and GCW, and a significant correlation existed between GWW and GWE. Within HCM subgroups characterized by increasing left ventricular outflow tract (LVOT) gradients, GWI\/GCW values exhibited \u201cpseudonormalization\u201d in the obstructive HCM groups, due to the offsetting effects of the nominal decrease in GLS and the nominal increase in LVOT gradient. In contrast, GWW values increased gradually with increasing LVOT gradients, and the difference compared to controls was significant even in the HCM group with LVOT gradients &amp;lt;10\u2005mmHg.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Given the strong correlation between GLS and GWI\/GCW, it is probable that changes in GLS would result in corresponding changes in GWI\/GCW, potentially limiting the incremental discriminatory value of these parameters beyond GLS. GWW appears to be the most independent MW parameter from GLS in patients with hypertrophic cardiomyopathy as it weakly correlates with GLS, unlike GWI\/GCW.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1670503","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:03:55Z","timestamp":1770793435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation of interrelations among myocardial work parameters in patients with hypertrophic cardiomyopathy: differences between non-obstructive and obstructive disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Vikt\u00f3ria","family":"Nagy","sequence":"first","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"R\u00e1cz","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Boda","sequence":"additional","affiliation":[{"name":"Department of Medical Physics and Informatics, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Tak\u00e1cs","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianka","family":"Polestyuk","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mi","family":"Schvartz","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3 D\u00e1niel","family":"Vid\u00e1cs","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen\u0151 Antal","family":"Pint\u00e9r","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"P\u00e1link\u00e1s","sequence":"additional","affiliation":[{"name":"Department of Medicine, Elisabeth Hospital","place":["H\u00f3dmez\u0151v\u00e1s\u00e1rhely, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Korm\u00e1nyos","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Sz\u0171csborus","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Borb\u00e1s","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Szili-T\u00f6r\u00f6k","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Sepp","sequence":"additional","affiliation":[{"name":"Division of Non-Invasive Cardiology, Cardiology Centre, Department of Internal Medicine, University of Szeged","place":["Szeged, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","article-title":"Deciphering the super relaxed state of human beta-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers","volume":"115","author":"Anderson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.hfc.2017.12.004","article-title":"Genetic pathogenesis of hypertrophic and dilated cardiomyopathy","volume":"14","author":"Garfinkel","year":"2018","journal-title":"Heart Fail Clin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/13543784.2020.1821361","article-title":"Mavacamten: a novel small molecule modulator of beta-cardiac myosin for treatment of hypertrophic cardiomyopathy","volume":"29","author":"Tower-Rader","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jacc.2022.04.048","article-title":"Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy","volume":"80","author":"Desai","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/jcdd10060261","article-title":"Left atrial strain imaging by speckle tracking echocardiography: the supportive diagnostic value in cardiac amyloidosis and hypertrophic cardiomyopathy","volume":"10","author":"Monte","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/diagnostics11030573","article-title":"Myocardial work: methodology and clinical applications","volume":"11","author":"Papadopoulos","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/jcecho.jcecho_37_24","article-title":"Clinical applications of myocardial work in echocardiography: a comprehensive review","volume":"34","author":"Trimarchi","year":"2024","journal-title":"J Cardiovasc Echogr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/eurheartj\/ehs016","article-title":"A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work","volume":"33","author":"Russell","year":"2012","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.echo.2020.05.010","article-title":"Myocardial work in nonobstructive hypertrophic cardiomyopathy: implications for outcome","volume":"33","author":"Hiemstra","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12872-023-03519-x","article-title":"Evaluation of global and regional myocardial work in hypertrophic cardiomyopathy patients by left ventricular pressure-strain loop","volume":"23","author":"Xiao","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12872-022-02740-4","article-title":"The value of myocardial work in assessment of ventricular function in patients with non-obstructive hypertrophic cardiomyopathy","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"767875","DOI":"10.3389\/fcvm.2022.767875","article-title":"Evaluation of myocardial work in patients with hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy based on non-invasive pressure-strain loops","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.21037\/jtd-23-202","article-title":"Left ventricular strain and myocardial work in apical hypertrophic cardiomyopathy","volume":"15","author":"Mihos","year":"2023","journal-title":"J Thorac Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.amjcard.2023.09.055","article-title":"Myocardial work appraisal in transthyretin cardiac amyloidosis and nonobstructive hypertrophic cardiomyopathy","volume":"208","author":"de Gregorio","year":"2023","journal-title":"Am J Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3390\/jcm13061671","article-title":"Systemic vascular resistance and myocardial work analysis in hypertrophic cardiomyopathy and transthyretin cardiac amyloidosis with preserved left ventricular ejection fraction","volume":"13","author":"de Gregorio","year":"2024","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.echo.2022.08.015","article-title":"Left ventricular myocardial work to differentiate cardiac amyloidosis from hypertrophic cardiomyopathy","volume":"36","author":"Stassen","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jshs.2022.07.004","article-title":"Specific alterations of regional myocardial work in strength-trained athletes using anabolic androgenic steroids compared to athletes with genetic hypertrophic cardiomyopathy","volume":"12","author":"Grandperrin","year":"2023","journal-title":"J Sport Health Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"927671","DOI":"10.3389\/fcvm.2022.927671","article-title":"Evaluation of exercise tolerance in non-obstructive hypertrophic cardiomyopathy with myocardial work and peak strain dispersion by speckle-tracking echocardiography","volume":"9","author":"Su","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e028857","DOI":"10.1161\/JAHA.122.028857","article-title":"Microvascular dysfunction is associated with impaired myocardial work in obstructive and nonobstructive hypertrophic cardiomyopathy: a multimodality study","volume":"12","author":"Garcia Bras","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s10554-021-02186-3","article-title":"Myocardial work is associated with significant left ventricular myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"37","author":"Goncalves","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s00246-024-03543-4","article-title":"Impaired myocardial work in children with hypertrophic cardiomyopathy and left ventricular fibrosis on cardiac magnetic resonance imaging","volume":"46","author":"Jacquemyn","year":"2024","journal-title":"Pediatr Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ehjci\/jead236","article-title":"Non-invasive estimation of left ventricular systolic peak pressure: a prerequisite to calculate myocardial work in hypertrophic obstructive cardiomyopathy","volume":"25","author":"Batzner","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ehjci\/jey188","article-title":"Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study","volume":"20","author":"Manganaro","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.jcmg.2018.07.016","article-title":"Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature","volume":"12","author":"Tower-Rader","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.amjcard.2021.04.021","article-title":"Usefulness of global longitudinal strain to predict heart failure progression in patients with nonobstructive hypertrophic cardiomyopathy","volume":"151","author":"Rowin","year":"2021","journal-title":"Am J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.amjcard.2017.05.039","article-title":"Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy","volume":"120","author":"Liu","year":"2017","journal-title":"Am J Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1093\/ehjci\/jead046","article-title":"Resting global longitudinal strain and stress echocardiography to detect coronary artery disease burden","volume":"24","author":"Gaibazzi","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.echo.2023.06.008","article-title":"Contrast stress echocardiography findings in myocardial bridging compared to normal coronary course, with and without coronary artery disease","volume":"36","author":"Guerra","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"133882","DOI":"10.1016\/j.ijcard.2025.133882","article-title":"Mavacamten effectively reduces >100\u2005mmHg left ventricular outflow tract gradients as early as one week of treatment in obstructive hypertrophic cardiomyopathy","volume":"442","author":"Nagy","year":"2026","journal-title":"Int J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1670503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:03:59Z","timestamp":1770793439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1670503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2025.1670503"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1670503","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"article-number":"1670503"}}